menu
    • menu

    Company profile for Ambys Medicines

    NEW Drugs in Dev: 1
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cell Therapies to Restore Liver Function & Regenerate the Liver Ambys is advancing an entirely new cell therapy approach to treat severe liver disease so that the millions of people affected will one day have treatments that can improve or save their lives. Liver diseases are among the most challenging and underserved areas of modern medicine. Despite some progress, most liver diseases – both chronic and acute – are not e...
    Cell Therapies to Restore Liver Function & Regenerate the Liver Ambys is advancing an entirely new cell therapy approach to treat severe liver disease so that the millions of people affected will one day have treatments that can improve or save their lives. Liver diseases are among the most challenging and underserved areas of modern medicine. Despite some progress, most liver diseases – both chronic and acute – are not effectively addressed by currently available treatments.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ambys MedicinesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    131 Oyster Point Blvd. Suite 200 South San Francisco, CA 94080
    Telephone
    Telephone
    650-481-7660
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ambys.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ambys-medicines/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ambysmedicines

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Moonshot' at liver cell therapy biotech Ambys Medicines comes to an end
    Moonshot' at liver cell therapy biotech Ambys Medicines comes to an end

    01 Feb 2023

    // ENDPTS

    https://endpts.com/moonshot-at-liver-cell-therapy-biotech-ambys-medicines-comes-to-an-end/

    ENDPTS
    01 Feb 2023
    Share Share
    Ambys Medicines Announces Formation of Clinical and Scientific Advisory Boards
    Ambys Medicines Announces Formation of Clinical and Scientific Advisory Boards

    27 Jun 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220627005077/en

    BUSINESSWIRE
    27 Jun 2022
    Share Share
    Ambys Medicines to Present New Data on Liver Cell Replacement Therapy Platform
    Ambys Medicines to Present New Data on Liver Cell Replacement Therapy Platform

    09 May 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220509005105/en

    BUSINESSWIRE
    09 May 2022
    Share Share
    Ambys Medicines Expands Leadership Team with Key Appointments
    Ambys Medicines Expands Leadership Team with Key Appointments

    20 Apr 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220420005037/en

    BUSINESSWIRE
    20 Apr 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search